Japan’s Otsuka Pharmaceutical buys out Claris’ 20% stake in JV for $ 20 mn (Business Standard May 9, 2017)
(Copyrights © 2017 Business Standard Private Ltd. All rights reserved.)
Japan’s Otsuka Pharmaceutical buys out Claris’ 20% stake in JV for $ 20 mn
With this, Otsuka to strengthen its basic IV solution and clinical nutrition business in India
Ahmedabad-based Claris Lifesciences has entered into a definitive agreement to sell its 20 percent stake in Otsuka Pharmaceutical India Pvt Ltd (formerly known as Claris Otsuka Pvt Ltd) to its joint venture partner, Otsuka Pharmaceutical Factory Inc (OPF) of Japan, for a total consideration of $ 20 million (about Rs 129 crore).